pN3-Control Citations (5)

Originally described in: Complexity of translationally controlled transcription factor Sp3 isoform expression.
Sapetschnig A, Koch F, Rischitor G, Mennenga T, Suske G J Biol Chem. 2004 Oct 1. 279(40):42095-105. PubMed Journal

---

Articles Citing pN3-Control

Articles
Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1. Lafleur VN, Richard S, Richard DE. Mol Biol Cell. 2014 Mar;25(6):925-35. doi: 10.1091/mbc.E13-07-0423. Epub 2014 Jan 22. PubMed
Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor alpha and IL-1beta in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3. Ye W, Zhou J, Markova DZ, Tian Y, Li J, Anderson DG, Shapiro IM, Risbud MV. Am J Pathol. 2015 Feb;185(2):485-95. doi: 10.1016/j.ajpath.2014.09.021. Epub 2014 Dec 2. PubMed
Regulation of a disintegrins and metalloproteinase with thrombospondin motifs 7 during inflammation in nucleus pulposus (NP) cells: role of AP-1, Sp1 and NF-kappaB signaling. Wang X, Li C, Liang A, Peng Y, Sun J, Huang D, Xu K, Ye W. Inflamm Res. 2016 Dec;65(12):951-962. Epub 2016 Aug 11. PubMed
Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer. Vaughan HJ, Zamboni CG, Radant NP, Bhardwaj P, Revai Lechtich E, Hassan LF, Shah K, Green JJ. Mol Ther Oncolytics. 2021 Apr 16;21:377-388. doi: 10.1016/j.omto.2021.04.004. eCollection 2021 Jun 25. PubMed
The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells. McDermott A, Kim K, Kasper S, Ho SM, Leung YK. Oncotarget. 2022 Jan 7;13:46-60. doi: 10.18632/oncotarget.28169. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.